Insights

Targeted Therapeutics Small company with a development-stage pipeline focused on tauopathies and dementia-related neurodegenerative conditions presents an opportunity to align with specialty biotech and neuroscience-focused funders, CROs, and potential collaborators seeking disease-modifying therapies.

Strategic Partnerships Engage with academic centers, contract research organizations, and biotech partners specializing in tau biology and biomarker development to accelerate preclinical validation, translational studies, and potential co-development or licensing deals.

Funding Focus Revenue under one million and a lean operation imply a strong appetite for grant support, government funding, and strategic collaborations with larger pharma seeking to minimize upfront risk while advancing tauopathy programs.

Key Leadership Access CEO and founder Shawn Mojtahedian is a recurring focal point at major healthcare conferences, offering direct engagement channels for investor briefings, partnership discussions, and business development conversations.

Market Positioning Position INT as a niche, tauopathy-focused biotech with global unmet medical need, opening doors to niche investors, philanthropic funders, and potential acquirers looking for early-stage dementia therapeutics with disease-modifying intent.

Similar companies to Innovative NeuroTechnologies, Inc.

Innovative NeuroTechnologies, Inc. Tech Stack

Innovative NeuroTechnologies, Inc. uses 8 technology products and services including Joomla, WordPress, WooCommerce, and more. Explore Innovative NeuroTechnologies, Inc.'s tech stack below.

  • Content Management System
  • Content Management System
  • E-commerce
  • Flickity
    Javascript Libraries
  • X-Content-Type-Options
    Web & Portal Technology
  • Cloudflare Insights
    Web Analytics
  • jQuery Waypoints
    Web Tools And Plugins

Media & News

Innovative NeuroTechnologies, Inc.'s Email Address Formats

Innovative NeuroTechnologies, Inc. uses at least 0 email formats:
Innovative NeuroTechnologies, Inc. Email FormatsExamplePercentage

Frequently Asked Questions

What is Innovative NeuroTechnologies, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Innovative NeuroTechnologies, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Innovative NeuroTechnologies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Innovative NeuroTechnologies, Inc.'s official website is innovneurotech.com and has social profiles on LinkedIn.

How much revenue does Innovative NeuroTechnologies, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Innovative NeuroTechnologies, Inc.'s annual revenue is estimated to be <$1M.

What is Innovative NeuroTechnologies, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Innovative NeuroTechnologies, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Innovative NeuroTechnologies, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Innovative NeuroTechnologies, Inc. has approximately 1 employees across 1 continents, including North America. Key team members include Founder, President, And Chief Executive Officer: S. M. Explore Innovative NeuroTechnologies, Inc.'s employee directory with LeadIQ.

What industry does Innovative NeuroTechnologies, Inc. belong to?

Minus sign iconPlus sign icon
Innovative NeuroTechnologies, Inc. operates in the Biotechnology Research industry.

What technology does Innovative NeuroTechnologies, Inc. use?

Minus sign iconPlus sign icon
Innovative NeuroTechnologies, Inc.'s tech stack includes Joomla, WordPress, WooCommerce, Microsoft 365, Flickity, X-Content-Type-Options, Cloudflare Insights and jQuery Waypoints.

When was Innovative NeuroTechnologies, Inc. founded?

Minus sign iconPlus sign icon
Innovative NeuroTechnologies, Inc. was founded in 2010.
Innovative NeuroTechnologies, Inc. logo

Innovative NeuroTechnologies, Inc.

Biotechnology ResearchCalifornia, United States0-1 Employees

Innovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company headquartered in Irvine, California, at 430 Goddard, Irvine, CA 92618, United States. The firm operates in a virtual mode and is pursuing a pipeline of biologically based, disease-modifying therapies aimed at preventing, delaying, or mitigating dementia or cognitive decline associated with tauopathies. Target conditions include Alzheimer's disease, frontotemporal dementia, chronic traumatic encephalopathy, progressive supranuclear palsy, corticobasal degeneration, familial FTDP-17, and Parkinson's disease dementia. These disorders share tau protein dysregulation, neurofibrillary tangles, synaptic dysfunction, and neuronal loss as underlying pathological features. The company is described as having a very small workforce (0-1 employees) and revenue in the range of $0-$1 million.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
0-1

Section iconFunding & Financials

  • <$1M

    Innovative NeuroTechnologies, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.